Relmada Therapeutics (RLMD) Cost of Revenue (2012 - 2026)
Relmada Therapeutics (RLMD) reported Cost of Revenue of $2.78 million for Q1 2026, compared with $155,600 a year earlier and up 9.5% from the prior quarter.
Powered by 
Analysis
Relmada Therapeutics (RLMD) Cost of Revenue (2012 - 2026) Analysis & Trends
Over the twelve months ended Mar 31, 2026, Relmada Therapeutics' Cost of Revenue came in at $6.16 million, up 330.7% year-over-year; for FY2025, it came in at $3.53 million, up 125.3% from FY2024.
- By year, Cost of Revenue came in at $1.57 million in FY2024.
- The Q1 2026 figure ranks as the highest quarterly Cost of Revenue in data going back to Q3 2012.
- Year over year, Cost of Revenue gained in two of the last four quarters, with growth averaging 196.4%.
- Per Business Quant data, the three quarters before Q1 2026 came in at $2.54 million (Q4 2025), $752,000 (Q3 2025) and $81,600 (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 3.27 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 8.10 Bn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 4.29 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | 4.40 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 3.71 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 2.52 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 2.81 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | 1.58 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 4.09 Bn |
| 10 | Relmada Therapeutics | 348.81 Mn | -209.78 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 2.78 Mn |
| Dec 31, 2025 | 2.54 Mn |
| Sep 30, 2025 | 752,000.00 |
| Jun 30, 2025 | 81,600.00 |
| Mar 31, 2025 | 155,600.00 |
| Dec 31, 2024 | 292,000.00 |
| Sep 30, 2024 | 301,400.00 |
| Jun 30, 2024 | 681,500.00 |
| Mar 31, 2024 | 292,500.00 |
| Nov 30, 2013 | 1,686.00 |
| May 31, 2013 | 322.00 |
| Feb 28, 2013 | 1,864.00 |
| Nov 30, 2012 | 1,850.00 |
| Aug 31, 2012 | 998.00 |
| May 31, 2012 | 292.00 |
API Access
Relmada Therapeutics Cost of Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=RLMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cost-of-revenue", "ticker": "RLMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=RLMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();